Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Thanks for the response Joe, guess your right, but it would have been nice to see what they would have said. Guess we got to try them all and see what works best for us as individuals. Have a great day!joe shmoe said:i dont know how many response you'll get for the very reason you stated...there is more than one protocol for this. and the thing is, everyones protocol has worked for them...and for others.
bottom line, which i think all would agree upon, is the fact that you should use hCG ATLEAST at the end.
have a nice day
PDP said:IMHO in shorter cycles it is not really needed.
In longer cycles I would suggest a midcycle period of use and one at the end prior to PCT. I advocate more frequent lower doses to avoid Leydig cell damage.
I would not suggest an AI if there is no XO aromatizing agents present. After all the goal is endocrine homeostasis which cannot truly be achieved with inhibited estrogen levels IMHO. Although androgenic activity may return, the potential of an inhibitory relapse when estrogen pops back on line is not worth it in my estimation.
Estrogen merely returns back to physiological levels, with possibly a very slight rise, after the cessation of the AI, thus removing the competitive inhibition of aromatase. However, you've now greatly enhanced the rate at which you achieve optimal levels of endogenous bioavailable test.....and you did so during the time when expediting the process was most crucial.PDP said:Although androgenic activity may return, the potential of an inhibitory relapse when estrogen pops back on line is not worth it in my estimation.
PDP said:Einstein, this has been debated. Estrogen is not the only inhibitory agent. Androgens, including DHT, are clearly inhibitory. Introducing an artificially low level of estrogen, and hence an artificially high level of androgen (relative to homeostatic levels given the recovery conditions) is not conducive to full HTPA recovery. Although aromatization of testosterone is not the only source of estrogen in the male body, extremely low levels of estrogen are not conducive to recovery of endogenous testosterone production due to the fact that GnRH receptors require estrogen so as to not down-regulate. If GnRH receptor concentration is low, LH production will be negatively impacted.
Again, the use of Arim or any other AI _IS_ beneficial but only while there exists supra-physiological levels of androgens. This usually lasts from 2-4 weeks after the last injection of long ester androgens. After that point the use of an AI is counterproductive.
The following is an illustration of my general recovery plan from say a 12 week cycle of moderate androgens.
Week 1- 17: AI
Week 12: Last injection of long acting androgen i.e. cyp
Week 12 -15: Exit Load - use of fast acting AAS i.e. prop
Week 12 14: HCG 1000iu EOD
Week 15 17: Intake of test powder dissolved in oil for lymphatic absorption (i.e. Andriol) morning only (mimic circadian test spike, reduction in catabolism, minimal effect on recovery)
Week 15 20: Nolv/Clo use with NO frontload.
If the subject is serious (and rich) then I would suggest an HGH and slin recovery strategy with injectable ATP etc. However I would then structure the protocol far differently.
You mention that there have been no negative reports when combing nolv/clo/arim. Well I have some for you. Do not run nolv/clo/arim all the way through recovery then drop them, this will yield poor results. With all due respect, PCT is much more complex than this, as Im sure you are well aware.
Great info. guys!PDP said:We gave Biggriz what he wanted, LOL. Let's agree to disagree on this one.
